{Reference Type}: Journal Article
{Title}: [Drug-associated osteonecrosis of the jaw with oral bisphosphonates in osteoporosis - periodontal diseases also harbor risks]
{Author}: Bornstein MM;Yeung AWK;Tanaka R;Su RY;
{Journal}: Swiss Dent J
{Volume}: 130
{Issue}: 5
{Year}: 2020 05 11
暂无{DOI}: 10.61872/sdj-2020-05-03
{Abstract}: During treatment with bisphosphonates (peroral or intravenous), there is a risk of osteonecrosis, "medication-related osteonecrosis of the jaw" (MRONJ), as a direct consequence of oral surgery or due to chronic infections such as periodontitis or peri-implantitis, particularly with high-dose medication in malignant patients. Necrosis of the jawbone has also been described with oral bisphosphonates in osteoporosis.